⌘K
Loading ticker…
Thermo Fisher Scientific, Inc. · Healthcare · Measuring & Control Equipment
As of 2026-06-26, Thermo Fisher Scientific, Inc. (TMO) has a 3-month relative strength percentile of 50 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 51. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 2.9%, relative volume 1.92×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
50 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
TMO is in a stage 1 base, week 1. Currently in a 107-day base; basing ADR 2.8% (broad 2.2%). VCP detected: inconclusive. RS line below base-start high. Distance from 50d / 200d: 8.1% / -2.4%.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
TMO is held by 16 ETFs as of Mar 2026. Top owner: VTI at 0.29% weight, $5.8B notional. Top 3 carry $12.9B.
Top 10 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.29% | $5.8B |
| VOOVanguard S&P 500 ETF | 0.33% | $4.7B |
| IVViShares Core S&P 500 ETF | 0.33% | $2.4B |
| SPYState Street SPDR S&P 500 ETF | 0.33% | $2.2B |
| VTVVanguard Value ETF | 0.75% | $1.7B |
| XLVState Street Health Care Select Sector SPDR ETF | 3.48% | $1.3B |
| IWDiShares Russell 1000 Value ETF | 0.61% | $426M |
| SPYMState Street SPDR Portfolio S&P 500 ETF | 0.33% | $388M |
| IVEiShares S&P 500 Value ETF | 0.68% | $319M |
| ITOTiShares Core S&P Total U.S. Stock Market ETF | 0.29% | $232M |
Showing 10 of 16 ETF owners.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | TMO Jan avg: 4.97% median: 2.56% win: 75% σ: 6.79% n: 4 2022-04-12 → 2026-05-29 | TMO Feb avg: -5.17% median: -7.47% win: 25% σ: 7.81% n: 4 2022-04-12 → 2026-05-29 | TMO Mar avg: -0.82% median: -1.87% win: 50% σ: 6.03% n: 4 2022-04-12 → 2026-05-29 | TMO Apr avg: -5.56% median: -3.72% win: 0% σ: 4.79% n: 5 2022-04-12 → 2026-05-29 | TMO May avg: -1.82% median: -0.13% win: 40% σ: 5.14% n: 5 2022-04-12 → 2026-05-29 | TMO Jun avg: -0.91% median: -0.99% win: 50% σ: 3.12% n: 4 2022-04-12 → 2026-05-29 (current) | TMO Jul avg: 10.39% median: 10.53% win: 100% σ: 4.17% n: 4 2022-04-12 → 2026-05-29 | TMO Aug avg: -0.42% median: 0.91% win: 75% σ: 6.03% n: 4 2022-04-12 → 2026-05-29 | TMO Sep avg: -4.28% median: -4.28% win: 25% σ: 4.54% n: 4 2022-04-12 → 2026-05-29 | TMO Oct avg: -1.37% median: -5.17% win: 50% σ: 13.74% n: 4 2022-04-12 → 2026-05-29 | TMO Nov avg: 5.38% median: 6.57% win: 75% σ: 6.40% n: 4 2022-04-12 → 2026-05-29 | TMO Dec avg: 0.42% median: -1.74% win: 25% σ: 4.43% n: 4 2022-04-12 → 2026-05-29 |